Mental Health Clinics in Osteen, FL Accepting Medicare
1 Mental Health Clinics found. Showing 1 - 1
 Mk Sallade Behavioral Inc Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 179 Rabbit Run, Osteen, FL 32764 Phone: 386-843-3006 |
News Archive
Glenmark initiates IND enabling studies of GBR 401 anti-CD19 monoclonal antibody in B cell lymphomas
Glenmark Pharmaceuticals announces the discovery and initiation of IND enabling studies of a Novel Biological Entity (NBE) lead candidate, GBR 401, an anti-CD19 monoclonal antibody. GBR 401 is developed completely in-house by Glenmark's Biologics Research Centre located in Switzerland.
Today's OpEds: The challenge of medicare spending; Two views of Massachussets; Regulating premiums
Health reform can be assessed from the perspective of four groups that collectively include most Americans. For those who are now in Medicaid or who are uninsured, reform will be a major gain. For those who obtain health insurance in the individual and small-group markets, reform should bring improvements. For those who have health insurance from midsize- and large-group insurers, reform will bring little change. Finally, for Medicare beneficiaries, reform promises to bring positive change.
DNA sequencing made portable and faster by "colour-blind" technology
Researchers at Baylor College of Medicine (BCM) and Rice University have developed a"colour-blind" method of fluorescence detection which could open new doors that would take DNA sequencing to the patient's bedside, the doctor's office and even the scene of a crime or a battlefield.
UB researchers show controlled individualized exercise training program relieves PCS
University at Buffalo researchers are the first to show that a controlled individualized exercise training program can bring athletes and others suffering with post-concussion syndrome (PCS) back to the playing field or to their daily activities.
Anacor Pharmaceuticals commences patient dosing in AN3365 Phase I clinical study
Anacor Pharmaceuticals today announced that it has dosed the first patient in a Phase I clinical study for AN3365, a novel boron-based, small-molecule drug candidate in development for the treatment of hospital infections caused by Gram-negative bacteria. The study will evaluate the safety, tolerability and pharmacokinetics of AN3365 in healthy volunteers.
› Verified 2 days ago